The biological basis for modern treatment of chordoma

Journal of Neuro-Oncology

Volumn 104, Issue 2, 2011, Pages 411-422

  Diaz, Roberto Jose ^a,b,c   Cusimano, Michael D ^c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Chemotherapy; Chordoma; Clinical outcome; Molecular therapy; Tumor biology

Indexed keywords

2 (4 HYDROXYPHENYL) 4 MORPHOLINOPYRIDO[3',2':4,5]FURO[3,2 D]PYRIMIDINE; ADRENALIN; BEVACIZUMAB; BISPHOSPHONIC ACID DERIVATIVE; BLEOMYCIN; CAMPTOTHECIN; CARBOPLATIN; CETUXIMAB; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB; IFOSFAMIDE; IMATINIB; MAMMALIAN TARGET OF RAPAMYCIN; MATRIX METALLOPROTEINASE INHIBITOR; MELANOMA ANTIGEN; METHOTREXATE; PROTEIN TYROSINE KINASE; RAPAMYCIN; STAT3 PROTEIN; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GENETICS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CHONDROMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISTANT METASTASIS; EXTRACELLULAR MATRIX; FLUID RETENTION; GAMMA KNIFE RADIOSURGERY; GASTROINTESTINAL TOXICITY; GENETIC DISORDER; HISTOPATHOLOGY; HUMAN; MOLECULAR PATHOLOGY; NEPHROTOXICITY; NOTOCHORD; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHOTON THERAPY; POSITRON EMISSION TOMOGRAPHY; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; RARE DISEASE; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; SKIN MANIFESTATION; SURVIVAL TIME; SYMPTOM; TREATMENT RESPONSE;

BONE NEOPLASMS; CHORDOMA; HUMANS;

EID: 80052619972     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0559-8     Document Type: Review

References (130)

1. ML McMaster AM Goldstein CM Bromley N Ishibe DM Parry 2001 Chordoma: incidence and survival patterns in the United States, 1973-1995 Cancer Causes Control 12 1 11 11227920 1:STN:280:DC%2BD3M3ksVylug%3D%3D (Pubitemid 32125896)
2. HD Dorfman B Czerniak 1995 Bone cancers Cancer 75 203 210 8000997 1:STN:280:DyaK2M%2FpsVWhsA%3D%3D
3. B Eriksson B Gunterberg LG Kindblom 1981 Chordoma. A clinicopathologic and prognostic study of a Swedish national series Acta Orthop Scand 52 49 58 7211316 1:STN:280:DyaL3M7ls1aktA%3D%3D (Pubitemid 11191378)
4. NL Higinbotham RF Phillips HW Farr HO Hustu 1967 Chordoma. Thirty-five-year study at Memorial Hospital Cancer 20 1841 1850 6061621 1:STN:280:DyaF1c%2FlsFahsA%3D%3D
5. HA Crockard T Steel N Plowman A Singh J Crossman T Revesz JL Holton A Cheeseman 2001 A multidisciplinary team approach to skull base chordomas J Neurosurg 95 175 183 10.3171/jns.2001.95.2.0175 11780885 1:STN:280: DC%2BD38%2FlsFGitg%3D%3D (Pubitemid 32799737)
6. YH Cho JH Kim SK Khang JK Lee CJ Kim 2008 Chordomas and chondrosarcomas of the skull base: comparative analysis of clinical results in 30 patients Neurosurg Rev 31 35 43 10.1007/s10143-007-0099-z 17922295 (discussion 43) (Pubitemid 350165355)
7. B Colli O Al-Mefty 2001 Chordomas of the craniocervical junction: follow-up review and prognostic factors J Neurosurg 95 933 943 10.3171/jns.2001.95.6.0933 11765837 1:STN:280:DC%2BD38%2FktVyisg%3D%3D (Pubitemid 33123849)
8. PA Forsyth TL Cascino EG Shaw BW Scheithauer JR O'Fallon JC Dozier DG Piepgras 1993 Intracranial chordomas: a clinicopathological and prognostic study of 51 cases J Neurosurg 78 741 747 10.3171/jns.1993.78.5.0741 8468605 1:STN:280:DyaK3s3isV2ksw%3D%3D (Pubitemid 23121915)
9. R Pallini G Maira F Pierconti ML Falchetti E Alvino G Cimino-Reale E Fernandez E D'Ambrosio LM Larocca 2003 Chordoma of the skull base: predictors of tumor recurrence J Neurosurg 98 812 822 10.3171/jns.2003.98.4.0812 12691407 (Pubitemid 36396784)
10. R Volpe A Mazabraud 1983 A clinicopathologic review of 25 cases of chordoma (a pleomorphic and metastasizing neoplasm) Am J Surg Pathol 7 161 170 6859391 1:STN:280:DyaL3s3ivVKqsQ%3D%3D (Pubitemid 13127295)
11. D Baratti A Gronchi E Pennacchioli L Lozza M Colecchia M Fiore M Santinami 2003 Chordoma: natural history and results in 28 patients treated at a single institution Ann Surg Oncol 10 291 296 12679315 1:STN:280: DC%2BD3s7mtFOrtA%3D%3D (Pubitemid 40486963)
12. MU Jawad SP Scully 2010 Surgery significantly improves survival in patients with chordoma Spine (Phila Pa 1976) 35 117 123 10.1097/BRS. 0b013e3181b44387
13. M Austin-Seymour J Munzenrider R Linggood M Goitein L Verhey M Urie R Gentry S Birnbaum D Ruotolo C Crowell, et al. 1990 Fractionated proton radiation therapy of cranial and intracranial tumors Am J Clin Oncol 13 327 330 2165739 1:STN:280:DyaK3czjsVSqsQ%3D%3D (Pubitemid 20262860)
14. EB Hug LN Loredo JD Slater A DeVries RI Grove RA Schaefer AE Rosenberg JM Slater 1999 Proton radiation therapy for chordomas and chondrosarcomas of the skull base J Neurosurg 91 432 439 10.3171/jns.1999.91.3.0432 10470818 1:STN:280:DyaK1MzpslCiuw%3D%3D (Pubitemid 29404435)
15. Ito E, Saito K, Okada T, Nagatani T, Nagasaka T (2009) Long-term control of clival chordoma with initial aggressive surgical resection and gamma knife radiosurgery for recurrence. Acta Neurochir (Wien). doi: 10.1007/s00701-009- 0535-7
16. T Hasegawa D Ishii Y Kida M Yoshimoto J Koike H Iizuka 2007 Gamma Knife surgery for skull base chordomas and chondrosarcomas J Neurosurg 107 752 757 10.3171/JNS-07/10/0752 17937219 (Pubitemid 47547738)
17. JJ Martin A Niranjan D Kondziolka JC Flickinger KA Lozanne LD Lunsford 2007 Radiosurgery for chordomas and chondrosarcomas of the skull base J Neurosurg 107 758 764 10.3171/JNS-07/10/0758 17937220 (Pubitemid 47547739)
18. J Bjornsson LE Wold MJ Ebersold ER Laws 1993 Chordoma of the mobile spine. a clinicopathologic analysis of 40 patients Cancer 71 735 740 8431853 1:STN:280:DyaK3s7mtFansA%3D%3D (Pubitemid 23051375)
19. RY Chandawarkar 1996 Sacrococcygeal chordoma: review of 50 consecutive patients World J Surg 20 717 719 8662159 1:STN:280:DyaK283ntVaqtQ%3D%3D (Pubitemid 26241038)
20. Choi D, Melcher R, Harms J, Crockard A Outcome of 132 operations in 97 patients with chordomas of the craniocervical junction and upper cervical spine. Neurosurgery 66: 59-65, discussion 65. doi: 10.1227/01.NEU.0000362000.35742.3D
21. FJ Wippold 2nd KK Koeller JG Smirniotopoulos 1999 Clinical and imaging features of cervical chordoma Am J Roentgenol 172 1423 1426 (Pubitemid 29507650)
22. BO Colli O Al-Mefty 2001 Chordomas of the skull base: follow-up review and prognostic factors Neurosurg Focus 10 E1 10.3171/foc.2001.10.3.2 16734401 1:STN:280:DC%2BD28zgvValsg%3D%3D
23. S Suster CA Moran 1995 Chordomas of the mediastinum: clinicopathologic, immunohistochemical, and ultrastructural study of six cases presenting as posterior mediastinal masses Hum Pathol 26 1354 1362 8522309 1:STN:280:DyaK287gsFCjtw%3D%3D (Pubitemid 26001598)
24. C Catton B O'Sullivan R Bell N Laperriere B Cummings V Fornasier J Wunder 1996 Chordoma: long-term follow-up after radical photon irradiation Radiother Oncol 41 67 72 8961370 1:STN:280:DyaK2s7itVKquw%3D%3D
25. PW Chambers CP Schwinn 1979 Chordoma. A clinicopathologic study of metastasis Am J Clin Pathol 72 765 776 389031 1:STN:280:DyaL3c%2Fmt1ekuw%3D%3D (Pubitemid 10158892)
26. AM Cesinaro A Maiorana G Annessi G Collina 1995 Cutaneous metastasis of chordoma Am J Dermatopathol 17 603 605 8599477 1:STN:280:DyaK287ms1yluw%3D%3D (Pubitemid 26010188)
27. J Llauger J Palmer S Amores S Bague A Camins 2000 Primary tumors of the sacrum: diagnostic imaging Am J Roentgenol 174 417 424 1:STN:280: DC%2BD3c7itFyjtw%3D%3D (Pubitemid 30067150)
28. SP Meyers WL Hirsch Jr HD Curtin L Barnes LN Sekhar C Sen 1992 Chordomas of the skull base: MR features Am J Neuroradiol 13 1627 1636 1442442 1:STN:280:DyaK3s%2FntFGktQ%3D%3D
29. K Almefty S Pravdenkova BO Colli O Al-Mefty M Gokden 2007 Chordoma and chondrosarcoma: similar, but quite different, skull base tumors Cancer 110 2457 2467 10.1002/cncr.23073 17894390 (Pubitemid 350174931)
30. MA Rossleigh J Smith SD Yeh 1986 Scintigraphic features of primary sacral tumors J Nucl Med 27 627 630 3712078 1:STN:280:DyaL283is1KnsQ%3D%3D
31. SA Park HS Kim 2008 F-18 FDG PET/CT evaluation of sacrococcygeal chordoma Clin Nucl Med 33 906 908 10.1097/RLU.0b013e31818c4e88 19033806
32. H Zhang K Yoshikawa K Tamura K Sagou M Tian T Suhara S Kandatsu K Suzuki S Tanada H Tsujii 2004 Carbon-11-methionine positron emission tomography imaging of chordoma Skeletal Radiol 33 524 530 10.1007/s00256-004-0815-5 15483754 (Pubitemid 39236657)
33. JX O'Connell LG Renard NJ Liebsch JT Efird JE Munzenrider AE Rosenberg 1994 Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases Cancer 74 2261 2267 7922977 (Pubitemid 24322280)
34. T Naka C Boltze A Samii C Herold H Ostertag Y Iwamoto Y Oda M Tsuneyoshi D Kuester A Roessner 2003 Skull base and nonskull base chordomas: clinicopathologic and immunohistochemical study with special reference to nuclear pleomorphism and proliferative ability Cancer 98 1934 1941 10.1002/cncr.11756 14584077 (Pubitemid 37310237)
35. HY Cho M Lee H Takei J Dancer JY Ro QJ Zhai 2009 Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma Appl Immunohistochem Mol Morphol 17 131 138 10.1097/PAI.0b013e3181866a13 19521276
36. R Tirabosco DC Mangham AE Rosenberg S Vujovic K Bousdras S Pizzolitto G De Maglio MA den Bakker L Di Francesco RK Kalil NA Athanasou P O'Donnell EF McCarthy AM Flanagan 2008 Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue Am J Surg Pathol 32 572 580 10.1097/PAS.0b013e31815b693a 18301055 (Pubitemid 351459578)
37. JR Salisbury 1993 The pathology of the human notochord J Pathol 171 253 255 10.1002/path.1711710404 8158454 1:STN:280:DyaK2c3htValsg%3D%3D (Pubitemid 24022985)
38. SR Henderson D Guiliano N Presneau S McLean R Frow S Vujovic J Anderson N Sebire J Whelan N Athanasou AM Flanagan C Boshoff 2005 A molecular map of mesenchymal tumors Genome Biol 6 R76 10.1186/gb-2005-6-9-r76 16168083
39. S Vujovic S Henderson N Presneau E Odell TS Jacques R Tirabosco C Boshoff AM Flanagan 2006 Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas J Pathol 209 157 165 10.1002/path.1969 16538613 1:CAS:528:DC%2BD28XmtlKisrg%3D (Pubitemid 43805410)
40. C Showell O Binder FL Conlon 2004 T-box genes in early embryogenesis Dev Dyn 229 201 218 10.1002/dvdy.10480 14699590 1:CAS:528:DC%2BD2cXht1egsL0%3D (Pubitemid 38036834)
41. S Romeo PC Hogendoorn 2006 Brachyury and chordoma: the chondroid-chordoid dilemma resolved? J Pathol 209 143 146 10.1002/path.1987 16604512 1:CAS:528:DC%2BD28XmtlKisro%3D (Pubitemid 43805408)
42. JB Park CK Lee JS Koh JK Lee EY Park KD Riew 2007 Overexpressions of nerve growth factor and its tropomyosin-related kinase A receptor on chordoma cells Spine (Phila Pa 1976) 32 1969 1973 10.1097/BRS.0b013e318133fbb5 (Pubitemid 47300998)
43. T Yamaguchi J Iwata S Sugihara EF McCarthy Jr M Karita H Murakami N Kawahara H Tsuchiya K Tomita 2008 Distinguishing benign notochordal cell tumors from vertebral chordoma Skeletal Radiol 37 291 299 10.1007/s00256-007-0435-y 18188556
44. T Yamaguchi S Suzuki H Ishiiwa Y Ueda 2004 Intraosseous benign notochordal cell tumors: overlooked precursors of classic chordomas? Histopathology 44 597 602 10.1111/j.1365-2559.2004.01877.x 15186275 1:STN:280:DC%2BD2c3os12itQ%3D%3D (Pubitemid 38845106)
45. V Deshpande GP Nielsen DI Rosenthal AE Rosenberg 2007 Intraosseous benign notochord cell tumors (BNCT): further evidence supporting a relationship to chordoma Am J Surg Pathol 31 1573 1577 10.1097/PAS.0b013e31805c9967 17895760 (Pubitemid 47482472)
46. KS Choi MJ Cohn BD Harfe 2008 Identification of nucleus pulposus precursor cells and notochordal remnants in the mouse: implications for disk degeneration and chordoma formation Dev Dyn 237 3953 3958 10.1002/dvdy.21805 19035356 1:CAS:528:DC%2BD1MXmvFWntg%3D%3D
47. Y Katoh M Katoh 2005 Hedgehog signaling pathway and gastric cancer Cancer Biol Ther 4 1050 1054 16258256 1:CAS:528:DC%2BD28XkvFGhtbk%3D (Pubitemid 41598556)
48. LM Anton Aparicio R Garcia Campelo J Cassinello Espinosa M Valladares Ayerbes M Reboredo Lopez S Diaz Prado G Aparicio Gallego 2007 Prostate cancer and Hedgehog signalling pathway Clin Transl Oncol 9 420 428 17652055 1:STN:280:DC%2BD2svjtFCjsg%3D%3D
49. CJ Hunter JR Matyas NA Duncan 2003 The notochordal cell in the nucleus pulposus: a review in the context of tissue engineering Tissue Eng 9 667 677 10.1089/107632703768247368 13678445 1:STN:280:DC%2BD3svjslGmsg%3D%3D (Pubitemid 37048109)
50. ML Deniz T Kilic I Almaata O Kurtkaya A Sav MN Pamir 2002 Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence Neurosurgery 51 753 760 12188955 discussion 760 (Pubitemid 36331070)
51. F Bayrakli I Guney T Kilic M Ozek MN Pamir 2007 New candidate chromosomal regions for chordoma development Surg Neurol 68 425 430 10.1016/j.surneu.2006. 11.046 17714767 discussion 430 (Pubitemid 47464455)
52. T Shih C Lindley 2006 Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies Clin Ther 28 1779 1802 10.1016/j.clinthera.2006. 11.015 17212999 1:CAS:528:DC%2BD2sXhtVClsbg%3D (Pubitemid 46038527)
53. KH Hallor J Staaf G Jonsson M Heidenblad F Vult von Steyern HC Bauer M Ijszenga PC Hogendoorn N Mandahl K Szuhai F Mertens 2008 Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation Br J Cancer 98 434 442 10.1038/sj.bjc.6604130 18071362 1:CAS:528:DC%2BD1cXhtVGqu74%3D (Pubitemid 351161241)
54. P Brandal B Bjerkehagen H Danielsen S Heim 2005 Chromosome 7 abnormalities are common in chordomas Cancer Genet Cytogenet 160 15 21 10.1016/j.cancergencyto.2004.11.016 15949565 1:CAS:528:DC%2BD2MXltFaqs70%3D (Pubitemid 40798131)
55. KK Almefty S Pravdenkova J Sawyer O Al-Mefty 2009 Impact of cytogenetic abnormalities on the management of skull base chordomas J Neurosurg 110 715 724 10.3171/2008.9.JNS08285 19133754
56. S Berven D Zurakowski HJ Mankin MC Gebhardt DS Springfield FJ Hornicek 2002 Clinical outcome in chordoma: utility of flow cytometry in DNA determination Spine (Phila Pa 1976) 27 374 379 (Pubitemid 34224652)
57. XR Yang D Ng DA Alcorta NJ Liebsch E Sheridan S Li AM Goldstein DM Parry MJ Kelley 2009 T (brachyury) gene duplication confers major susceptibility to familial chordoma Nat Genet 41 1176 1178 10.1038/ng.454 19801981 1:CAS:528:DC%2BD1MXht1WgsbzP
58. AA Shalaby N Presneau BD Idowu L Thompson TR Briggs R Tirabosco TC Diss AM Flanagan 2009 Analysis of the fibroblastic growth factor receptor-RAS/RAF/ MEK/ERK-ETS2/brachyury signalling pathway in chordomas Mod Pathol 22 996 1005 10.1038/modpathol.2009.63 19407855 1:CAS:528:DC%2BD1MXpsVKns70%3D
59. L Klingler R Trammell DG Allan MG Butler HS Schwartz 2006 Clonality studies in sacral chordoma Cancer Genet Cytogenet 171 68 71 10.1016/j. cancergencyto.2006.06.007 17074594 1:CAS:528:DC%2BD28XhtFequrbI (Pubitemid 44740442)
60. M Longoni F Orzan M Stroppi N Boari P Mortini P Riva 2008 Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study Neuro Oncol 10 52 60 10.1215/15228517-2007-048 18094369 1:CAS:528:DC%2BD1cXivFKgsbk%3D (Pubitemid 351250900)
61. P Riva F Crosti F Orzan L Dalpra P Mortini A Parafioriti B Pollo AM Fuhrman Conti M Miozzo L Larizza 2003 Mapping of candidate region for chordoma development to 1p36.13 by LOH analysis Int J Cancer 107 493 497 10.1002/ijc.11421 14506752 1:CAS:528:DC%2BD3sXos1Gnsb4%3D (Pubitemid 37266472)
62. S Scheil S Bruderlein T Liehr H Starke J Herms M Schulte P Moller 2001 Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1 Genes Chromosomes Cancer 32 203 211 10.1002/gcc.1184 11579460 1:CAS:528:DC%2BD3MXnvVGhu7k%3D (Pubitemid 32953974)
63. Sommer J, Itani DM, Homlar KC, Keedy VL, Halpern JL, Holt GE, Schwartz HS, Coffin CM, Kelley MJ, Cates JM Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma. J Pathol 220:608-617. doi: 10.1002/path.2679
64. KD Robertson PA Jones 1999 Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus Oncogene 18 3810 3820 10.1038/sj.onc.1202737 10445844 1:CAS:528:DyaK1MXks1Omtrw%3D (Pubitemid 29358559)
65. M Lubin A Lubin 2009 Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy PLoS One 4 e5735 10.1371/journal.pone.0005735 19478948
66. B Laguda C Selden M Jones H Hodgson NK Spurr 1991 Assignment of the hepatocyte growth factor (HGF) to chromosome 7q22-qter Ann Hum Genet 55 213 216 1837206 1:STN:280:DyaK387gvFChtw%3D%3D
67. Liu X, Newton RC, Scherle PA (2009) Developing c-MET pathway inhibitors for cancer therapy: progress and challenges. Trends Mol Med. doi: 10.1016/j.molmed.2009.11.005
68. JH Schwab PJ Boland NP Agaram ND Socci T Guo GC O'Toole X Wang E Ostroumov CJ Hunter JA Block S Doty S Ferrone JH Healey CR Antonescu 2009 Chordoma and chondrosarcoma gene profile: implications for immunotherapy Cancer Immunol Immunother 58 339 349 10.1007/s00262-008-0557-7 18641983 1:CAS:528:DC%2BD1MXitlCjtw%3D%3D
69. T Naka D Kuester C Boltze TO Schulz A Samii C Herold H Ostertag A Roessner 2008 Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma Hum Pathol 39 217 223 10.1016/j.humpath.2007.06.005 17949787 1:CAS:528:DC%2BD1cXovFKqug%3D%3D
70. CM Overall O Kleifeld 2006 Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy Nat Rev Cancer 6 227 239 10.1038/nrc1821 16498445 1:CAS:528:DC%2BD28Xhslelt70%3D (Pubitemid 43292566)
71. O Teronen P Heikkila YT Konttinen M Laitinen T Salo R Hanemaaijer A Teronen P Maisi T Sorsa 1999 MMP inhibition and downregulation by bisphosphonates Ann N Y Acad Sci 878 453 465 10415748 1:CAS:528: DyaK1MXkslemsL0%3D (Pubitemid 29353588)
72. A Mittelman ZJ Chen CC Liu S Hirai S Ferrone 1994 Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23 Cancer Res 54 415 421 8275478 1:STN:280: DyaK2c7gtFKitg%3D%3D
73. E Tamborini F Miselli T Negri MS Lagonigro S Staurengo GP Dagrada S Stacchiotti E Pastore A Gronchi F Perrone A Carbone MA Pierotti PG Casali S Pilotti 2006 Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas Clin Cancer Res 12 6920 6928 10.1158/1078-0432.CCR-06-1584 17145809 1:CAS:528: DC%2BD28Xht1Kns7vO (Pubitemid 44974484)
74. JH Fasig WD Dupont BJ LaFleur SJ Olson JM Cates 2008 Immunohistochemical analysis of receptor tyrosine kinase signal transduction activity in chordoma Neuropathol Appl Neurobiol 34 95 104 10.1111/j.1365-2990.2007.00873.x 17973908 1:STN:280:DC%2BD1c%2FksFShuw%3D%3D
75. PM Weinberger Z Yu D Kowalski J Joe P Manger A Psyrri CT Sasaki 2005 Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies Arch Otolaryngol Head Neck Surg 131 707 711 10.1001/archotol.131.8.707 16103303 (Pubitemid 41186892)
76. T Naka D Kuester C Boltze S Scheil-Bertram A Samii C Herold H Ostertag S Krueger A Roessner 2008 Expression of hepatocyte growth factor and c-MET in skull base chordoma Cancer 112 104 110 10.1002/cncr.23141 17948912
77. Y Dobashi S Suzuki E Sato Y Hamada T Yanagawa A Ooi 2009 EGFR-dependent and independent activation of Akt/mTOR cascade in bone and soft tissue tumors Mod Pathol 22 1328 1340 10.1038/modpathol.2009.104 19648884 1:CAS:528: DC%2BD1MXhtF2ltbrO
78. N Presneau A Shalaby B Idowu P Gikas SR Cannon I Gout T Diss R Tirabosco AM Flanagan 2009 Potential therapeutic targets for chordoma: PI3 K/AKT/TSC1/TSC2/mTOR pathway Br J Cancer 100 1406 1414 10.1038/sj.bjc.6605019 19401700 1:CAS:528:DC%2BD1MXltFGit7c%3D
79. N Singhal D Kotasek FX Parnis 2009 Response to erlotinib in a patient with treatment refractory chordoma Anticancer Drugs 20 953 955 10.1097/CAD.0b013e328330c7f0 19730087 1:CAS:528:DC%2BD1MXht1GitrjO
80. H Hof T Welzel J Debus 2006 Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma Onkologie 29 572 574 10.1159/000096283 17202828 (Pubitemid 46005781)
81. O Linden L Stenberg E Kjellen 2009 Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib Acta Oncol 48 158 159 10.1080/02841860802266672 18752082
82. EK Rowinsky 2004 Targeting the molecular target of rapamycin (mTOR) Curr Opin Oncol 16 564 575 15627018 1:CAS:528:DC%2BD2cXhtVOqt7bN (Pubitemid 39482975)
83. AR MacKenzie M von Mehren 2007 Mechanisms of mammalian target of rapamycin inhibition in sarcoma: present and future Expert Rev Anticancer Ther 7 1145 1154 10.1586/14737140.7.8.1145 18028023 1:CAS:528:DC%2BD2sXptFynt7g%3D (Pubitemid 47365007)
84. L Lee-Jones I Aligianis PA Davies A Puga PA Farndon A Stemmer-Rachamimov V Ramesh JR Sampson 2004 Sacrococcygeal chordomas in patients with tuberous sclerosis complex show somatic loss of TSC1 or TSC2 Genes Chromosomes Cancer 41 80 85 10.1002/gcc.20052 15236319 1:CAS:528:DC%2BD2cXntVelu70%3D (Pubitemid 38988740)
85. J Borgel H Olschewski T Reuter B Miterski JT Epplen 2001 Does the tuberous sclerosis complex include clivus chordoma? A case report Eur J Pediatr 160 138 11271387 1:STN:280:DC%2BD3M7ntV2htw%3D%3D (Pubitemid 32204545)
86. Kimmell KT, Dayoub H, Stolzenberg ED, Sincoff EH Chordoma in the lateral medullary cistern in a patient with tuberous sclerosis: a case report and review of the literature. Surg Neurol Int 1: 13. doi: 10.4103/2152-7806.63908
87. N Hay N Sonenberg 2004 Upstream and downstream of mTOR Genes Dev 18 1926 1945 10.1101/gad.1212704 15314020 1:CAS:528:DC%2BD2cXmvFKqsLk%3D (Pubitemid 39071573)
88. S Stacchiotti A Marrari E Tamborini E Palassini E Virdis A Messina F Crippa C Morosi A Gronchi S Pilotti PG Casali 2009 Response to imatinib plus sirolimus in advanced chordoma Ann Oncol 20 1886 1894 10.1093/annonc/mdp210 19570961 1:STN:280:DC%2BD1MjhvVCisA%3D%3D
89. J Schwab C Antonescu P Boland J Healey A Rosenberg P Nielsen J Iafrate T Delaney S Yoon E Choy D Harmon K Raskin C Yang H Mankin D Springfield F Hornicek Z Duan 2009 Combination of PI3 K/mTOR inhibition demonstrates efficacy in human chordoma Anticancer Res 29 1867 1871 19528441 1:CAS:528:DC%2BD1MXos1Wnurs%3D
90. C Yang JH Schwab AJ Schoenfeld FJ Hornicek KB Wood GP Nielsen E Choy H Mankin Z Duan 2009 A novel target for treatment of chordoma: signal transducers and activators of transcription 3 Mol Cancer Ther 8 2597 2605 10.1158/1535-7163.MCT-09-0504 19723879 1:CAS:528:DC%2BD1MXhtFCis7vO
91. MU Jawad SP Scully 2010 Surgery significantly improves survival in patients with chordoma Spine (Phila Pa 1976) 35 117 123 10.1097/BRS. 0b013e3181b44387
92. JH Schwab JH Healey P Rose J Casas-Ganem PJ Boland 2009 The surgical management of sacral chordomas Spine (Phila Pa 1976) 34 2700 2704 10.1097/BRS.0b013e3181bad11d
93. PC Hsieh R Xu DM Sciubba MJ McGirt C Nelson TF Witham JP Wolinksy ZL Gokaslan 2009 Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients Spine (Phila Pa 1976) 34 2233 2239 10.1097/BRS.0b013e3181
94. F Tzortzidis F Elahi DC Wright N Temkin SK Natarajan LN Sekhar 2006 Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chondrosarcomas Neurosurgery 58 1090 1098 10.1227/01.NEU. 0000215892.65663.54 16723888 discussion 1090-1098
95. S Boriani S Bandiera R Biagini P Bacchini L Boriani M Cappuccio F Chevalley A Gasbarrini P Picci JN Weinstein 2006 Chordoma of the mobile spine: fifty years of experience Spine (Phila Pa 1976) 31 493 503 10.1097/01.brs. 0000200038.30869.27 (Pubitemid 43361752)
96. C Ares EB Hug AJ Lomax A Bolsi B Timmermann HP Rutz JC Schuller E Pedroni G Goitein 2009 Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report Int J Radiat Oncol Biol Phys 75 1111 1118 10.1016/j.ijrobp.2008.12.055 19386442
97. G Noel L Feuvret V Calugaru F Dhermain H Mammar C Haie-Meder D Ponvert D Hasboun R Ferrand C Nauraye G Boisserie A Beaudre G Gaboriaud A Mazal JL Habrand JJ Mazeron 2005 Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams Acta Oncol 44 700 708 10.1080/02841860500326257 16227160 (Pubitemid 41547070)
98. FC Henderson K McCool J Seigle W Jean W Harter GJ Gagnon 2009 Treatment of chordomas with CyberKnife: georgetown university experience and treatment recommendations Neurosurgery 64 A44 A53 10.1227/01.NEU.0000341166.09107.47 19165073
99. Durante M, Loeffler JS (2010) Charged particles in radiation oncology. Nat Rev Clin Oncol 7:37-43. doi: 10.1038/nrclinonc.2009.183
100. E Ostroumov CJ Hunter 2007 The role of extracellular factors in human metastatic chordoma cell growth in vitro Spine (Phila Pa 1976) 32 2957 2964 10.1097/BRS.0b013e31815cde91 (Pubitemid 350307277)
101. D Schulz-Ertner CP Karger A Feuerhake A Nikoghosyan SE Combs O Jakel L Edler M Scholz J Debus 2007 Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas Int J Radiat Oncol Biol Phys 68 449 457 10.1016/j.ijrobp.2006.12.059 17363188 (Pubitemid 46694169)
102. P Sonveaux A Brouet X Havaux V Gregoire C Dessy JL Balligand O Feron 2003 Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy Cancer Res 63 1012 1019 12615716 1:CAS:528:DC%2BD3sXhs1agt74%3D (Pubitemid 36278432)
103. R Chugh R Dunn MM Zalupski JS Biermann VK Sondak JR Mace KM Leu WF Chandler LH Baker 2005 Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma J Clin Oncol 23 3597 3604 10.1200/JCO.2005.02.170 15908670 1:CAS:528:DC%2BD2MXlsVyhs70%3D
104. PG Casali A Messina S Stacchiotti E Tamborini F Crippa A Gronchi R Orlandi C Ripamonti C Spreafico R Bertieri R Bertulli M Colecchia E Fumagalli A Greco F Grosso P Olmi MA Pierotti S Pilotti 2004 Imatinib mesylate in chordoma Cancer 101 2086 2097 10.1002/cncr.20618 15372471 1:CAS:528:DC%2BD2cXhtVShtb7J (Pubitemid 39425386)
105. StacchiottiS FV G Ferraresi F Grignani A Crippa E Messina CS Tamborini A Gronchi PG Casali 2007 Imatinib mesylate in advanced chordoma: a multicenter phase II study J Clin Oncol 25 10003
106. F Orzan MR Terreni M Longoni N Boari P Mortini C Doglioni P Riva 2007 Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas Oncol Rep 18 249 252 17549375 1:CAS:528: DC%2BD2sXot1Kls7k%3D
107. Ferraresi V, Nuzzo C, Zoccali C, Marandino F, Vidiri A, Salducca N, Zeuli M, Giannarelli D, Cognetti F, Biagini R (2010) Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients. BMC Cancer 10:22. doi: 10.1186/1471-2407-10-22
108. Casali PG, Stacchiotti S, Grosso F, Messina A, Crippa F, Tamborini E, Bertieri R, Collini P, Pilotti S, Gronchi A (2007) Adding cisplatin (CDDP) to imatinib (IM) re-establishes tumor response following secondary resistance to IM in advanced chordoma. 2007 ASCO Annual Meeting Proceedings Part I, Vol 25, No. 18S. J Clin Oncol(June 20 Suppl):10038
109. Stacchiotti S, Grosso F, Dileo P et al (2006) Antitumor activity of imatinib plus cisplatin in two patients with advanced chordoma. In: Proceedings of 12th Annual Connective Tissue Oncology Society Meeting 2006, 58 (Abstr 725)
110. GF Fleming PS Heimann JK Stephens MA Simon MK Ferguson RS Benjamin BL Samuels 1993 Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases Cancer 72 714 718 8334623 1:STN:280:DyaK3szislehsw%3D%3D (Pubitemid 23215255)
111. PG Scimeca AG James-Herry KS Black E Kahn ME Weinblatt 1996 Chemotherapeutic treatment of malignant chordoma in children J Pediatr Hematol Oncol 18 237 240 8846149 1:STN:280:DyaK283gvFOlsw%3D%3D (Pubitemid 26163488)
112. A Azzarelli V Quagliuolo S Cerasoli R Zucali P Bignami V Mazzaferro G Dossena L Gennari 1988 Chordoma: natural history and treatment results in 33 cases J Surg Oncol 37 185 191 3352273 1:STN:280:DyaL1c7ntlGktQ%3D%3D (Pubitemid 18095868)
113. S Guiu B Guiu S Feutray B Chauffert 2009 Direct intratumoral chemotherapy with carboplatin and epinephrine in a recurrent cervical chordoma: case report Neurosurgery 65 E629 E630 10.1227/01.NEU.0000350864.78326.14 19687674 discussion E630
114. C Parr AJ Sanders WG Jiang 2009 Hepatocyte growth factor activation inhibitors-therapeutic potential in cancer Anticancer Agents Med Chem 10 47 57
115. JP Eder GF Vande Woude SA Boerner PM LoRusso 2009 Novel therapeutic inhibitors of the c-Met signaling pathway in cancer Clin Cancer Res 15 2207 2214 10.1158/1078-0432.CCR-08-1306 19318488 1:CAS:528:DC%2BD1MXjvVWltrY%3D
116. ME Keisch DM Garcia RB Shibuya 1991 Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution J Neurosurg 75 374 377 10.3171/jns.1991.75.3.0374 1869936 1:STN:280:DyaK3Mzjt1KmtA%3D%3D
117. S Boriani F Chevalley JN Weinstein R Biagini L Campanacci F De Iure P Piccill 1996 Chordoma of the spine above the sacrum treatment and outcome in 21 cases Spine (Phila Pa 1976) 21 1569 1577 1:STN:280:DyaK28vhsVOrtw%3D%3D
118. O al-Mefty LA Borba 1997 Skull base chordomas: a management challenge J Neurosurg 86 182 189 10.3171/jns.1997.86.2.0182 9010416 1:STN:280: DyaK2s7mtlKjuw%3D%3D (Pubitemid 27130674)
119. JE York A Kaczaraj D Abi-Said GN Fuller JM Skibber NA Janjan ZL Gokaslan 1999 Sacral chordoma: 40-year experience at a major cancer center Neurosurgery 44 74 79 9894966 1:STN:280:DyaK1M7htVamtQ%3D%3D discussion 79-80
120. P Bergh LG Kindblom B Gunterberg F Remotti W Ryd JM Meis-Kindblom 2000 Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients Cancer 88 2122 2134 10.1002/(SICI)1097-0142(20000501)88:9<2122::AID- CNCR19>3.0.CO;2-1 10813725 1:STN:280:DC%2BD3c3ntlCqtA%3D%3D (Pubitemid 30233215)
121. A Carpentier M Polivka A Blanquet G Lot B George 2002 Suboccipital and cervical chordomas: the value of aggressive treatment at first presentation of the disease J Neurosurg 97 1070 1077 10.3171/jns.2002.97.5.1070 12450028 (Pubitemid 35253543)
122. B Fuchs ID Dickey MJ Yaszemski CY Inwards FH Sim 2005 Operative management of sacral chordoma J Bone Joint Surg Am 87 2211 2216 10.2106/JBJS.D.02693 16203885 (Pubitemid 41407545)
123. F Tzortzidis F Elahi D Wright SK Natarajan LN Sekhar 2006 Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas Neurosurgery 59 230 237 10.1227/01.NEU.0000223441.51012.9D 16883163 discussion 230-237 (Pubitemid 44325841)
124. A Samii VM Gerganov C Herold N Hayashi T Naka MJ Mirzayan H Ostertag M Samii 2007 Chordomas of the skull base: surgical management and outcome J Neurosurg 107 319 324 10.3171/JNS-07/08/0319 17695386 (Pubitemid 47219375)
125. S Takahashi T Kawase K Yoshida A Hasegawa JE Mizoe 2009 Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy Acta Neurochir (Wien) 151 759 769 10.1007/s00701-009-0383-5
126. BJ Jian OG Bloch I Yang SJ Han D Aranda T Tihan AT Parsa 2010 Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma J Neurooncol 98 101 108 10.1007/s11060-009-0068-1 19953297
127. D Choi R Melcher J Harms A Crockard 2010 Outcome of 132 operations in 97 patients with chordomas of the craniocervical junction and upper cervical spine Neurosurgery 66 59 65 10.1227/01.NEU.0000362000.35742.3D 20023538 discussion 65
128. S Stacchiotti PG Casali S Lo Vullo L Mariani E Palassini M Mercuri M Alberghini S Pilotti L Zanella A Gronchi P Picci 2010 Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers Ann Surg Oncol 17 211 219 10.1245/s10434-009- 0740-x 19847568
129. P Ruggieri A Angelini G Ussia M Montalti M Mercuri 2010 Surgical margins and local control in resection of sacral chordomas Clin Orthop Relat Res 468 2939 2947 10.1007/s11999-010-1472-8 20635173
130. Z Wu J Zhang L Zhang G Jia J Tang L Wang Z Wang 2010 Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas-106 cases review in one institution Neurosurg Rev 33 451 456 10.1007/s10143-010-0273-6 20668904